CClinicalTrials.gg
Status unknownNCT02557165Updated Sep 23, 2015

Impact of COPD on Muscle Regeneration

An observational study in COPD, sponsored by Laval University. Status unknown. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-09-23.

Sponsored by Laval University · Observational

The sponsor has not verified this record recently (last verified Sep 2015), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
27
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD) and can affect both respiratory and peripheral muscles. Impaired muscle regeneration is thought to be implicated in the process of muscle atrophy. In this study the investigators will evaluate muscle regenerative potential of the Vastus Lateralis (VL) and diaphragm of patients with COPD, compared to patients with normal lung function.

Read the detailed description

Preliminary results suggest that the activation and differentiation processes of satellite cells isolated from the VL of patients with COPD could be altered. The investigators propose to compare the regenerative potential of the VL and the diaphragm in 15 patients with COPD and 15 individuals with normal lung function undergoing a thoracic surgery. From muscle biopsies, satellite cells will be isolated and cultured to assess their proliferation and differentiation rates, and the expression level of myogenic effectors (MyoD, Myf5, myogenin, and MRF4). Alterations in these measurements will confirm the hypotheses that the regenerative potential is lower in both muscle groups in patients with COPD compared to controls and that in COPD, the regenerative potential is lower in VL compared to the diaphragm.

02

Conditions studied

  • COPD

Keywords

  • Muscle regeneration
03

In context

Lead sponsor

Laval University is the lead sponsor of 371 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient with a scheduled thoracic surgery

Inclusion criteria

  • Patient with a scheduled thoracic surgery
  • ≥ 40 years
  • Smoking cessation ≥ 1 month
  • Smoking history ≥ 10 pack-year

Exclusion criteria

Exclusion Criteria:

  • Subjects who received either chemiotherapy or radiotherapy
  • Hypoxemia
  • Body weight loss ≥ 10%
  • Use of systemic corticosteroid in the last month
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
27 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • COPD patients

    Patients with mild to moderate COPD having a scheduled lung surgery. Vastus lateralis and diaphragm muscle biopsies performed during surgery

    Procedure: Muscle biopsies

  • Patients with normal lung function

    Patients with normal lung function having a scheduled lung surgery. Vastus lateralis and diaphragm muscle biopsies performed during surgery.

    Procedure: Muscle biopsies

Interventions

  • ProcedureMuscle biopsies

    Muscle biopsies will allow acces to samples for observational studies. Vastus latetalis: needle biopsy (Bergstrom technique). Diaphragm: open biopsy performed by thoracic surgeon during lung surgery.

06

What researchers measure

Primary outcomes

  1. Muscle satellite cell proliferation index

    Isolation from muscle biopsies of satellite cell to evaluate their regeneration capacity by evaluating the proliferation capacity

    Time frame: Sequential analyses performed over a period of 2 weeks after tissue collection.

  2. Muscle satellite cell differentiation index

    Isolation from muscle biopsies of satellite cell to evaluate their regeneration capacity by evaluating the differentiation capacity

    Time frame: Sequential analyses performed over a period of 2 months after tissue collection.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Theriault ME, Pare ME, Lemire BB, Maltais F, Debigare R. Regenerative defect in vastus lateralis muscle of patients with chronic obstructive pulmonary disease. Respir Res. 2014 Mar 25;15(1):35. doi: 10.1186/1465-9921-15-35. PubMed 24666540 ↗
  • Theriault ME, Pare ME, Maltais F, Debigare R. Satellite cells senescence in limb muscle of severe patients with COPD. PLoS One. 2012;7(6):e39124. doi: 10.1371/journal.pone.0039124. Epub 2012 Jun 13. PubMed 22720047 ↗
  • Caron MA, Debigare R, Dekhuijzen PN, Maltais F. Comparative assessment of the quadriceps and the diaphragm in patients with COPD. J Appl Physiol (1985). 2009 Sep;107(3):952-61. doi: 10.1152/japplphysiol.00194.2009. Epub 2009 Apr 9. PubMed 19359618 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02557165
Lead sponsor
Laval University
Collaborators
GlaxoSmithKline
Responsible party
Sponsor
First posted
Sep 23, 2015
Start date
Jan 2011
Primary completion
Jun 2015
Completion
Dec 2015 (estimated)
Last update
Sep 23, 2015

Study contacts

Richard Debigare, PhD, PT
principal investigator · Laval University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion